# Haploidentical Hematopoietic Stem Cell Transplantation Patients With Wiskott-Aldrich Syndrome

> **NCT00160355** · PHASE1 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 4 (actual)

## Conditions studied

- Wiskott-Aldrich Syndrome

## Interventions

- **PROCEDURE:** Hematopoietic stem cell transplantation
- **DEVICE:** Miltenyi CliniMACS selection system
- **DRUG:** Fludarabine, Melphalan, Thiotepa

## Key facts

- **NCT ID:** NCT00160355
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2008-07
- **Final completion:** 2009-02
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2017-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00160355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00160355, "Haploidentical Hematopoietic Stem Cell Transplantation Patients With Wiskott-Aldrich Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00160355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*